Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)

Trial Locations

Juravinski Cancer Centre Hamilton, Ontario, Canada
- Contact: Theos Tsakiridis, Dr. · 001-905-525-9140 · [email protected] (opens in new tab)
The Ottawa Hospital Regional Cancer Centre Ottawa, Ontario, Canada
- Contact: Scott Morgan, MD
University Health Network Princess Margaret Cancer Centre Toronto, Ontario, Canada
- Contact: Dr Aruz Mesci, MD · (416) 946-4501 Ext. 4709 · [email protected] (opens in new tab)
Jewish General Hospital Montreal, Quebec, Canada
- Contact: Melanie Research Coordinator · 514-340-8222 · [email protected] (opens in new tab)
McGill University Health Centre (MUHC) - Glen Site Montreal, Quebec, Canada
- Contact: Dr Marie Duclos, MD · 514-934-8040 · [email protected] (opens in new tab)

No results